Gene polymorphisms in the cyclophosphamide metabolism pathway correlate with complications after haplo-HSCT

Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is used as curative...

Real-world QOL survey for patients with acute and chronic GvHD post allo-SCT in 5 European countries

Graft-versus-host disease (GvHD) is a major limitation and complication after allogeneic stem cell...

ROCKstar: Belumosudil in chronic GvHD, an update from EBMT 2021

The Rho-associated coiled-coil kinase 2 (ROCK2) pathway is accountable for the regulation of Th17/regulatory T (Treg) cells and...

A phase II trial of PTCy versus ATG for GvHD prophylaxis after RIC regimen allo-HCT

The development of graft-versus-host disease (GvHD) can significantly impact the outcomes of patients who have...

COVID-19 vaccination for hematopoietic stem cell transplant patients

The SARS-CoV-2 pandemic has changed the world over the last year and impacted almost every part of our lives. In particular,...

How can we use microbial-derived metabolites to prevent GvHD?

During the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the GvHD Hub spoke to Erik Thiele...

NCCN COVID-19 vaccination recommendations for patients with hematologic malignancies

Patients with cancer are at high risk of COVID-19-associated complications and, accordingly, the preliminary...

Ruxolitinib fails to provide clinical benefit in patients with COVID-19-related cytokine storm

he efficacy and safety of adding ruxolitinib to standard of care (SoC) for patients with...

Are you planning a phase II study of glasdegib in refractory sclerotic chronic GvHD?

During the EHA2021 Virtual Congress, the GvHD Hub spoke with Eduardo Rodriguez Arboli, University of Seville,...

Key communications on GvHD at EHA 2021

During the EHA2021 Virtual Congress, the GvHD Hub spoke with Mohamad Mohty, Hôpital Saint-Antoine, Paris, FR. We asked, What were the key communications on GvHD...

Gene polymorphisms in the cyclophosphamide metabolism pathway correlate with complications after haplo-HSCT

Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is used as curative...

A dose-ranging study of GvHD prophylaxis with PTB in patients with refractory acute leukemia

Patients with acute myeloid leukemia (AML) who are refractory to standard chemotherapy regimens have a poor...